← Leaderboards
Ravi Jasuja
University Of California-Irvine
$7,178,750
Attributed
$7,178,750
Total exposure
7
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.6M · FY2008–25$2M$1.5M$1M$500K$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$7,178,750 · 7
By mechanism
R44$3,962,492 · 1
P30$1,857,362 · 3
R33$1,132,667 · 1
R43$225,000 · 1
P41$1,229 · 1
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Performance”
- Jeffrey P Krischer · University Of South Florida$413,069,911
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$378,749,497
- Gary D Acton · University Of California-Davis$320,373,312
- Mitchell J Malone · Texas A&M Research Foundation$320,373,312
- Lawrence Corey · Fred Hutchinson Cancer Center$319,618,139
- Gerald T Nepom · Benaroya Research Inst At Virginia Mason$298,740,071
Research focus
PerformanceMeasurementFundingResearch PersonnelPhysical FunctionFatty Acid Glycerol EstersAgingPre-ClinicalAnimal ModelReproducibilityInnovationMuscle FormPre-Clinical ModelBaseBostonInstitutionStandardizationValidationGrantResourcesImpairmentBody CompositionImaging ModalityInstrument
Grant awards (19)
Pre Clinical Discovery Core$225,124
P30 · FY2025 · AG · contact PI
Pre Clinical Discovery Core$224,834
P30 · FY2024 · AG · contact PI
Phase IIB: Development of TruT Algorithm for Commercialization in Androgen Disorders$948,808
R44 · FY2023 · AG · contact PI
Pre Clinical Discovery Core$186,156
P30 · FY2023 · AG · contact PI
Phase IIB: Development of TruT Algorithm for Commercialization in Androgen Disorders$1,008,781
R44 · FY2022 · AG · contact PI
Preclinical Characterization of Novel Formulation for Sustained Testosterone Delivery$375,019
R33 · FY2022 · AG · contact PI
Pre Clinical Discovery Core$222,943
P30 · FY2022 · AG · contact PI
Preclinical Characterization of Novel Formulation for Sustained Testosterone Delivery$382,324
R33 · FY2021 · AG · contact PI
Pre Clinical Discovery Core$218,077
P30 · FY2021 · AG · contact PI
Preclinical Characterization of Novel Formulation for Sustained Testosterone Delivery$375,324
R33 · FY2020 · AG · contact PI
Preclinical Discovery Core$162,560
P30 · FY2020 · AG · contact PI
Preclinical Discovery Core$162,494
P30 · FY2019 · AG · contact PI
Phase II: Research and Commercialization of TruT Algorithm for Free Testosterone$975,187
R44 · FY2018 · AG · contact PI
Preclinical Discovery Core$162,368
P30 · FY2018 · AG · contact PI
Phase II: Research and Commercialization of TruT Algorithm for Free Testosterone$1,029,716
R44 · FY2017 · AG · contact PI
Preclinical Discovery Core$147,772
P30 · FY2017 · AG · contact PI
Preclinical Discovery Core$145,034
P30 · FY2016 · AG · contact PI
Novel Algorithm for Free Testosterone Determination$225,000
R43 · FY2014 · AG · contact PI
LIGAND-INDUCED CONFORMATIONAL DYNAMICS IN ANDROGEN RECEPTOR & CO-ACTIVATORS$1,229
P41 · FY2008 · RR · contact PI